Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Cancer Research|January 10, 2019
HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy-Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout MiceElin M V Forsberg, Mattias F Lindberg, Henrik Jespersen, et al.Biorxiv : the Preprint Server for Biology|May 25, 2026
Ciliogenesis associated kinase 1 accumulates in its inactive form during polycystic kidney disease progressionAlice Serafin, Charlène Coquil, Aurore Dupuy, et al.JCO Precision Oncology|September 11, 2020
Mutational Signature and Transcriptomic Classification Analyses as the Decisive Diagnostic Tools for a Cancer of Unknown PrimaryRoger Olofsson Bagge, Akif Demir, Joakim Karlsson, et al.Cell Death & Disease|February 8, 2020
Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanomaBerglind O Einarsdottir, Joakim Karlsson, Elin M V Söderberg, et al.Cell Death & Disease|July 26, 2018
A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanomaBerglind O Einarsdottir, Joakim Karlsson, Elin M V Söderberg, et al.Journal of Medicinal Chemistry|December 5, 2023
Chemical, Biochemical, Cellular, and Physiological Characterization of Leucettinib-21, a Down Syndrome and Alzheimer's Disease Drug CandidateMattias F Lindberg, Emmanuel Deau, Frédéric Miege, et al.Journal of Medicinal Chemistry|December 20, 2021
Structure-Activity Relationship in the Leucettine Family of Kinase InhibitorsTania Tahtouh, Emilie Durieu, Benoît Villiers, et al.Cancer Research|June 29, 2017
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ SignalingMarco Donia, Katja Harbst, Marit van Buuren, et al.Pageof 3